BMY Bristol-Myers Squibb Company

-

Bristol-Myers Squibb Beat Consensus Estimates, Raises Guidance

Thursday, October 29, 2026 · 6:59 AM ET

Bristol-Myers Squibb (BMY) reported earnings of $1.35 per share on revenue of $13.07 billion for the third quarter ended September 2026. The consensus earnings estimate was $1.21 per share on revenue of $12.56 billion. The company beat consensus estimates by 11.57% while revenue grew 6.93% on a year-over-year basis.

The company said it expects 2026 non-GAAP earnings of $6.95 to $7.15 per share, excluding items of $0.60 per share, on revenue of $49.75 billion to $50.25 billion. The company's previous guidance was earnings of $6.75 to $7.00 per share on revenue of $49.0 billion to $50.0 billion, and the current consensus earnings estimate is $6.51 per share on revenue of $49.83 billion for the year ending December 31, 2026.

Bristol-Myers Squibb Co is a biopharmaceutical company. It discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products.

Earnings Whisper Grade —
Power Rating—
Reported Earnings
$1.35
Earnings Whisper®
—
Consensus Estimate
$1.21
Earnings Surprise
Earnings Growth-17.2 %
Reported Revenue
$13.07B
Revenue Estimate
$12.56B
Revenue Surprise
Revenue Growth6.9 %

Bristol Myers Squibb Reports Third Quarter Financial Results for 2026

Thursday, October 29, 2026 · 6:59 AM ET Business Wire

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today reported third quarter 2026 financial results.

Visit the company’s Investor Relations website at http://investor.bms.com to view the detailed third quarter 2026 earnings press release and investor presentation.

The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, October 29, 2026, which is accessible here. Company executives will review financial results with the investment community during the call.

A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes.

About Bristol Myers Squibb: Transforming Patients' Lives Through Science
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook and Instagram.

corporatefinancial-news

For more information, contact:
Media Relations: media@bms.com
Investor Relations: investor.relations@bms.com

Source: Bristol Myers Squibb